Precigen

20358 Seneca Meadows Parkway
Germantown MD 20876
Share:
About Us

Precigen is a dedicated discovery and clinical stage biopharmaceutical company advancing the next generation of gene and cellular therapies using precision technology to target the most urgent and intractable diseases in immuno-oncology, autoimmune disorders, and infectious diseases. Our technologies enable us to find innovative solutions for affordable biotherapeutics in a controlled manner. Precigen operates as an innovation engine progressing a preclinical and clinical pipeline of well-differentiated unique therapies toward clinical proof-of-concept and commercialization. Precigen was founded as a wholly-owned subsidiary of Intrexon Corporation(NASDAQ: XON) and leverages Intrexon’s proprietary technology platforms to advance human health.

Powered By GrowthZone

MTC NEW MEMBERS